Laxmi Organic Industries Limited has informed the Exchange regarding Outcome of Board Meeting dated July 28, 2025 for approval of Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2025
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved Q1 FY26 (June 30, 2025) unaudited standalone and consolidated results. Standalone revenue from operations fell to ₹6,719.09 million from ₹7,184.45 million a year ago (down ~6.5% YoY), while profit after tax dropped to ₹229.70 million from ₹352.06 million (down ~34.7%). Consolidated revenue declined to ₹6,929.30 million and PAT fell to ₹213.91 million from ₹343.51 million. EPS stood at ₹0.83 (standalone) and ₹0.77 (consolidated). Two important items flatter the numbers: the company switched its depreciation method from Written Down Value to Straight Line Method (which alone lowered depreciation by ₹244.68 million – without it, standalone PBT would have been a loss of ₹67.15 million), and a revised income tax rate of 25.17% under Section 115BBA led to a one-time deferred tax reversal of ₹97.18 million. Comparatives were also restated following the amalgamation of wholly-owned subsidiary Yellowstone Fine Chemicals Private Limited, effective March 30, 2025. Deloitte Haskins & Sells LLP issued a clean limited-review report.
Headline profits remain positive but underlying operating performance is weak – core earnings power has clearly compressed, and the reported PAT is propped up by an accounting change in depreciation and a tax-rate adjustment. The actual profit before tax (₹177.53 mn standalone) is a fraction of last year's ₹583.76 mn, so shareholders should look through the headline and focus on operating margins. The stock may see pressure given the steep YoY decline in profits and softer revenue, despite the optics of growth in PAT.